Therefore, their replacement with CD4+CD25+ Treg cells obtained from normal donors or in vitro expanded autologous functional CD4+CD25+ Treg represents a new paradigm for immunotherapy of autoimmune diseases. The gene discussed is IL2RA; the disease is autoimmune disease.